🦊/Lists

Biotech Investors & VC Firms in Europe

841 firms in this list, with a median first check of $500K. 192 of them lead rounds. Generated from verified public data and updated continuously.

Optum Ventures
BostonSeed–Late Stage
35 people
Taiwania Capital
TaipeiSeed–Growth$3M – $85M
46 people
Nexxus Capital
Mexico CityGrowth$15M – $50M
51 people
Eight Roads Ventures
MumbaiSeed–Late Stage$5M – $30M
20 people
Illumina Ventures
Foster CityPre-Seed–Late Stage
41 people
Lightstone Ventures
Portola ValleyPre-Seed–Late Stage
32 people
LOWERCARBON
JacksonPre-Seed–Growth$1M – $50M
17 people
Ampersand
BostonGrowth
36 people
SR One Capital Management
Redwood CitySeed–Series B
32 people
HEALTHCARE ROYALTY PARTNERS
New York
29 people
Wavemaker Three-Sixty Health
Los AngelesSeed–Series A$500K – $2M
27 people
OMERS Ventures
TorontoPre-Seed–Series C$5M – $25M
16 people
Oxford Finance LLC
AlexandriaSeed–Late Stage$5M – $125M
45 people
DRI Healthcare
Toronto$7.3M – $36.5M
44 people
Blume Ventures
MumbaiSeed–Late Stage$650K – $36M
21 people
VantagePoint Capital Partners
Silicon ValleySeed–Late Stage$2M – $100M
19 people
Avoro Capital Advisors
New YorkSeed–Series A
22 people
Mission Biocapital
San FranciscoPre-Seed–Series A$500K
21 people
M Ventures
Los AngelesSeed–Growth$10.8M
6 people
UntroD Capital
TokyoPre-Seed–Growth$772K – $241M
5 people
GroveStreet
NewtonSeries A–Late Stage
41 people
TMV
New YorkPre-Seed–Series A$1.5M
14 people
Safar Partners
CambridgePre-Seed–Late Stage
17 people
SVG Ventures | THRIVE
Silicon ValleyPre-Seed–Series A$10K – $100K
30 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.